{"id": "patient_01_q0", "query": "Which of the following is NOT part of the current treatment regimen for Mrs. Sample's DLBCL?", "options_scores": {"A": 0.05818561837077141, "B": 0.21357521414756775, "C": 0.0012471494264900684, "D": 0.09963786602020264, "E": 0.031984154134988785}, "ranked_options": [{"letter": "C", "text": "Cyclophosphamide", "avg_nll": 0.0012471494264900684}, {"letter": "E", "text": "Doxorubicin", "avg_nll": 0.031984154134988785}, {"letter": "A", "text": "Polatuzumab vedotin", "avg_nll": 0.05818561837077141}, {"letter": "D", "text": "Vincristine", "avg_nll": 0.09963786602020264}, {"letter": "B", "text": "Rituximab", "avg_nll": 0.21357521414756775}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q1", "query": "In the context of Mrs. Sample's other diagnoses, which of the following is NOT accurate based on the provided information?", "options_scores": {"A": 1.4974572658538818, "B": 0.5961441993713379, "C": 1.4507362842559814, "D": 0.8062942624092102, "E": 1.7456098794937134}, "ranked_options": [{"letter": "B", "text": "She was diagnosed with primary progressive type of multiple sclerosis.", "avg_nll": 0.5961441993713379}, {"letter": "D", "text": "She has 3-vessel CHD.", "avg_nll": 0.8062942624092102}, {"letter": "C", "text": "She has a mood disorder.", "avg_nll": 1.4507362842559814}, {"letter": "A", "text": "She has 2-vessel disease", "avg_nll": 1.4974572658538818}, {"letter": "E", "text": "She has pre-existing ALS.", "avg_nll": 1.7456098794937134}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q2", "query": "Which chronic, neuroinflammatory disease does Mrs. Sample suffer from? ", "options_scores": {"A": 0.6826980113983154, "B": 0.5045796036720276, "C": 0.004426324740052223, "D": 3.7724461555480957, "E": 0.7698360085487366}, "ranked_options": [{"letter": "C", "text": "Parkinson", "avg_nll": 0.004426324740052223}, {"letter": "B", "text": "Dementia", "avg_nll": 0.5045796036720276}, {"letter": "A", "text": "Multiple sclerosis", "avg_nll": 0.6826980113983154}, {"letter": "E", "text": "Autoimmune encephalitis", "avg_nll": 0.7698360085487366}, {"letter": "D", "text": "Brain abscess", "avg_nll": 3.7724461555480957}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q3", "query": "Mrs. Sample takes Fingolimod. What is the dosis and when does the patient take it?", "options_scores": {"A": 1.3223882913589478, "B": 1.5081068277359009, "C": 1.7069636583328247, "D": 2.5951406955718994, "E": 1.9444619417190552}, "ranked_options": [{"letter": "A", "text": "0.5 mg, 1 capsule in the morning", "avg_nll": 1.3223882913589478}, {"letter": "B", "text": "0.5 mg, 1 capsule at bedtime", "avg_nll": 1.5081068277359009}, {"letter": "C", "text": "50 mg, 1 capsule in the morning", "avg_nll": 1.7069636583328247}, {"letter": "E", "text": "70 mg, 1 capsule in the morning", "avg_nll": 1.9444619417190552}, {"letter": "D", "text": "35 mg, 1 capsule at bedtime", "avg_nll": 2.5951406955718994}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q4", "query": "Which therapy regime does the oncology board recommend for Mrs. Sample?", "options_scores": {"A": 3.881676435470581, "B": 4.227063179016113, "C": 3.5308029651641846, "D": 0.5995469689369202, "E": 4.483016014099121}, "ranked_options": [{"letter": "D", "text": "6 cycles of R-Pola-CHP", "avg_nll": 0.5995469689369202}, {"letter": "C", "text": "6 cycles of L-Pola-CRP", "avg_nll": 3.5308029651641846}, {"letter": "A", "text": "5 cycles of T-Pola-RHP", "avg_nll": 3.881676435470581}, {"letter": "B", "text": "7 cycles of R-Luna-CHT", "avg_nll": 4.227063179016113}, {"letter": "E", "text": "8 cycles of M-Pola-CHZ", "avg_nll": 4.483016014099121}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q5", "query": "Mrs. Sample has bone metastasis, of which one was surgically addressed. Where was this metastasis located? ", "options_scores": {"A": 2.1290016174316406, "B": 2.173644542694092, "C": 0.27841994166374207, "D": 1.2237324714660645, "E": 1.583107352256775}, "ranked_options": [{"letter": "C", "text": "Thoracic vertebra 10", "avg_nll": 0.27841994166374207}, {"letter": "D", "text": "Thoracic vertebra 11", "avg_nll": 1.2237324714660645}, {"letter": "E", "text": "Thoracic vertebra 12", "avg_nll": 1.583107352256775}, {"letter": "A", "text": "Thoracic vertebra 8", "avg_nll": 2.1290016174316406}, {"letter": "B", "text": "Thoracic vertebra 9", "avg_nll": 2.173644542694092}], "correct_answer_letter": "C", "error": null, "method": "local"}
{"id": "patient_01_q6", "query": "On 01/09/2017, Mrs. Sample received a CT scan of her whole body. What kind of contrast agent was used?", "options_scores": {"A": 1.0624468326568604, "B": 1.9458833932876587, "C": 0.4166051149368286, "D": 3.4077961444854736, "E": 1.7493630647659302}, "ranked_options": [{"letter": "C", "text": "Optiray 320", "avg_nll": 0.4166051149368286}, {"letter": "A", "text": "Omnipaque 320", "avg_nll": 1.0624468326568604}, {"letter": "E", "text": "Xenetix 350", "avg_nll": 1.7493630647659302}, {"letter": "B", "text": "Imeron 400", "avg_nll": 1.9458833932876587}, {"letter": "D", "text": "Gadovist", "avg_nll": 3.4077961444854736}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q7", "query": "Mrs. Sample received multiple radiologic examinations. In which order did she receive them?", "options_scores": {"A": 2.18941330909729, "B": 1.4173235893249512, "C": 1.8293384313583374, "D": 2.0189013481140137, "E": 1.9479442834854126}, "ranked_options": [{"letter": "B", "text": "MR Brain > MR thoracic/lumbar spine > CT chest/abdomen/pelvis > CT Thoracic Spine > CT Thoracic Spine > CT chest/abdomen/pelvis > Abdominal ultrasound > MR Spine > Whole-body PET/CT > Liver MRI", "avg_nll": 1.4173235893249512}, {"letter": "C", "text": "MR cervical spine > MR Head > CT Whole Body > CT Thoracic Spine", "avg_nll": 1.8293384313583374}, {"letter": "E", "text": "CT Thoracic Spine > CT Whole Body > MR cervical spine > MR Head", "avg_nll": 1.9479442834854126}, {"letter": "D", "text": "MR Brain > CT Thoracic Spine > MR cervical spine > CT Whole Body", "avg_nll": 2.0189013481140137}, {"letter": "A", "text": "MR spine > MR Head > CT Thoracic Spine > CT Whole Body", "avg_nll": 2.18941330909729}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q8", "query": "Mrs. Sample’ medications changed between admission and discharge. Which of the following statements is correct?", "options_scores": {"A": 1.3791110515594482, "B": 2.89387583732605, "C": 1.0157588720321655, "D": 2.591029644012451, "E": 2.904571294784546}, "ranked_options": [{"letter": "C", "text": "The dose of Sertraline hydrochloride was increased from 50 mg to 100 mg.", "avg_nll": 1.0157588720321655}, {"letter": "A", "text": "Aspirin was discontinued.", "avg_nll": 1.3791110515594482}, {"letter": "D", "text": "The patient started taking prednisolone and is recommended to continue taking it for the rest of her life.", "avg_nll": 2.591029644012451}, {"letter": "B", "text": "The patient started taking Pregabalin 50 mg, 1-0-0-0", "avg_nll": 2.89387583732605}, {"letter": "E", "text": "The patient started taking 2mg of Melatonin in the evening.", "avg_nll": 2.904571294784546}], "correct_answer_letter": "E", "error": null, "method": "local"}
{"id": "patient_01_q9", "query": "Based on the medication changes from admission to discharge, which of the following best describes the Mrs Sample's evolving clinical situation?", "options_scores": {"A": 2.2755582332611084, "B": 1.5834099054336548, "C": 1.9710255861282349, "D": 1.7909921407699585, "E": 2.2301101684570312}, "ranked_options": [{"letter": "B", "text": "The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake.", "avg_nll": 1.5834099054336548}, {"letter": "D", "text": "The patient's mood disorder was deemed stabilized, leading to the discontinuation of Sertraline at discharge.", "avg_nll": 1.7909921407699585}, {"letter": "C", "text": "The patient developed a new gastrointestinal issue, hence the introduction of Pantoprazole at discharge.", "avg_nll": 1.9710255861282349}, {"letter": "E", "text": "The patient's immobility concerns were resolved, leading to the discontinuation of Enoxaparin sodium (Clexane®) at discharge.", "avg_nll": 2.2301101684570312}, {"letter": "A", "text": "The patient's cardiovascular risk was decreased, leading to a reduced number of cardiovascular medications at discharge.", "avg_nll": 2.2755582332611084}], "correct_answer_letter": "B", "error": null, "method": "local"}
